Correlation Between Recursion Pharmaceuticals and UniCredit

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and UniCredit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and UniCredit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and UniCredit 5459 percent, you can compare the effects of market volatilities on Recursion Pharmaceuticals and UniCredit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of UniCredit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and UniCredit.

Diversification Opportunities for Recursion Pharmaceuticals and UniCredit

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Recursion and UniCredit is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and UniCredit 5459 percent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UniCredit 5459 percent and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with UniCredit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UniCredit 5459 percent has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and UniCredit go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and UniCredit

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 12.12 times less return on investment than UniCredit. But when comparing it to its historical volatility, Recursion Pharmaceuticals is 7.64 times less risky than UniCredit. It trades about 0.03 of its potential returns per unit of risk. UniCredit 5459 percent is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  8,202  in UniCredit 5459 percent on September 12, 2024 and sell it today you would earn a total of  136.00  from holding UniCredit 5459 percent or generate 1.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy85.86%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  UniCredit 5459 percent

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
UniCredit 5459 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UniCredit 5459 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for UniCredit 5459 percent investors.

Recursion Pharmaceuticals and UniCredit Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and UniCredit

The main advantage of trading using opposite Recursion Pharmaceuticals and UniCredit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, UniCredit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UniCredit will offset losses from the drop in UniCredit's long position.
The idea behind Recursion Pharmaceuticals and UniCredit 5459 percent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data